Sommetrics Closing Series D Financing Round to Advance Sleep Apnea Device
Proceeds from the financing round will be used in part to finish the pivotal trial for aerSleep II and file for FDA market clearance.
Proceeds from the financing round will be used in part to finish the pivotal trial for aerSleep II and file for FDA market clearance.
This is an important milestone for Sommetrics,” says Kent Gandola. “It reflects the continuing effort of our employees to build a solid foundation for making the transition from a R&D company to one poised for commercial success.”